Home
GI Innovation

GI Innovation Market Share Analysis for June 2026

Great Integration and Innovation to cure diseases by developing breakthrough biologics.

Health > Medicine

Domaingi-innovation.com

Year Founded2017

Employees51 - 200

Annual Revenue$10M - $15M

GI Innovation

GI Innovation (including company regionals)

gi-innovation.com

See more website traffic and engagement information

GI Innovation Revenue up to June 2026 is 10M - 15M

revenue generated by GI Innovation top domains

GI Innovation top domains revenue over 3 years

Revenue for GI Innovation top domains

gi-innovation.com10M - 15M

See more with Sales Intelligence

Total visits to GI Innovation's top domains

Understand GI Innovation market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

gi-innovation.com39.2K

See more with Sales Intelligence

Avg. visit duration in GI Innovation's top domains

Analyze GI Innovation engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

gi-innovation.com00:09:15

See more with Sales Intelligence

Avg. pageviews on GI Innovation's top domains

See how GI Innovation keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

gi-innovation.com6.23

See more with Sales Intelligence

GI Innovation top competitors by domain

Top similar sites in June 2026, ranked by their affinity

biointron.comCompany NameBiointronEmployees201 - 500HQChina, shanghaiAnnual revenue$100M - $200MTotal visits45.5KHealth > Health Conditions and Concerns

Top technologies used by GI Innovation

These are the website technologies, by industry, used by GI Innovation top domains

Advertising (3)

Google Adsense

Widget (3)

reCAPTCHA

Mobile (2)

Meta Viewport

Audio Video Media (1)

YouTube

More Technologies

6

See all

News & Signals from GI Innovation

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGI Innovation Inc. partnered with Johnson & Johnson on Mar 20th '26.SEOUL, South Korea, March 20, 2026 /PRNewswire/ - GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) in a phase 1b clinical trial.

NewsGI Innovation Inc. partnered with LaNova Medicines Limited on Jan 22nd '25.SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ - GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development of GI-102 and ADC pancreatic cancer combination therapy.

NewsGI Innovation Inc. partners with Merck.South Korean biotech company GI Innovation has entered a clinical trial collaboration and supply agreement with Merck & Co (MSD) to assess GI-102 in combination with Keytruda (pembrolizumab) for various types of cancer.